Literature DB >> 28845052

Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.

Margaret Formago1, Michael G Schrauder1, Claudia Rauh1, Carolin C Hack1, Sebastian M Jud1, Thomas Hildebrandt1, Rüdiger Schulz-Wendtland2, S Frentz3, S Graubert3, Matthias W Beckmann1, Michael P Lux1.   

Abstract

INTRODUCTION: The care of patients with breast cancer is extremely complex and requires interdisciplinary care in certified facilities. These specialized facilities provide numerous services without being correspondingly remunerated. The question whether breast cancer surgery should be performed in an outpatient setting to reduce costs is increasingly being debated. This study compares inpatient surgical treatment with a model of the same surgery performed on an outpatient basis to examine the potential financial impact.
MATERIAL AND METHODS: A theoretical model was developed and the DRG fees for surgical interventions to treat primary breast cancer were calculated. A theoretical 1-day DRG was then calculated to permit comparisons with outpatient procedures. The costs of outpatient surgery were calculated based on the remuneration rates of the AOP (Outpatient Surgery) Contract and the EBM (Uniform Assessment Scale) and compared to the costs of the 1-day DRG.
RESULTS: The DRG fee for both breast-conserving surgery and mastectomy is higher than the fee paid in the context of the EBM system, although the same procedures were carried out in both systems. If a hospital were to carry out breast-conserving surgery as an outpatient procedure, the fee would be € 1313.81; depending on the type of surgery, the hospital would therefore only receive between 39.20% and 52.82% of the DRG fee. This was the case even for a 1-day treatment. Compared to the real DRG fees the difference would be even more striking.
CONCLUSION: Carrying out breast cancer surgery as an outpatient procedure would result in a significant shortfall of revenues. Additional services from certified centers, such as the interdisciplinary planning of treatment, psycho-oncological and social-medical care with the involvement of relatives, detailed documentation, etc., which are currently provided without surcharge or adequate remuneration, could no longer be maintained. The quality of processes and excellent results which have been achieved and ultimately the care given by certified facilities would be significantly at risk.

Entities:  

Keywords:  DRG (Diagnosis Related Groups); EBM (Uniform Assessment Scale); breast cancer; outpatient setting; surgery

Year:  2017        PMID: 28845052      PMCID: PMC5570589          DOI: 10.1055/s-0043-114427

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  10 in total

1.  Are Certified Breast Centers Cost-Effective?

Authors:  Matthias W Beckmann; Mayada R Bani; Christian R Loehberg; Thomas Hildebrandt; Michael G Schrauder; Stefanie Wagner; Peter A Fasching; Michael Patrick Lux
Journal:  Breast Care (Basel)       Date:  2009-08-14       Impact factor: 2.860

Review 2.  Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology.

Authors:  M P Lux; P A Fasching; C R Loehberg; S M Jud; M G Schrauder; M R Bani; F C Thiel; C C Hack; T Hildebrandt; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

3.  Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

Authors:  J Heil; A Gondos; G Rauch; F Marmé; J Rom; M Golatta; H Junkermann; P Sinn; S Aulmann; J Debus; H Hof; F Schütz; H Brenner; C Sohn; A Schneeweiss
Journal:  Breast       Date:  2012-02-05       Impact factor: 4.380

4.  Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients.

Authors:  Matthias W Beckmann; Cosima Brucker; Volker Hanf; Claudia Rauh; Mayada R Bani; Stefanie Knob; Sabrina Petsch; Stefan Schick; Peter A Fasching; Arndt Hartmann; Michael P Lux; Lothar Häberle
Journal:  Onkologie       Date:  2011-06-15

5.  Financing of certified centers: a willingness-to-pay analysis.

Authors:  Falk C Thiel; Anton Scharl; Thomas Hildebrandt; Efstratios Kotziabassis; Michael G Schrauder; Mayada R Bani; Andreas Müller; Tanja Hauzenberger; Christian R Loehberg; Sebastian M Jud; Peter A Fasching; Arndt Hartmann; Rüdiger Schulz-Wendtland; Vratislav Strnad; Matthias W Beckmann; Michael Patrick Lux
Journal:  Arch Gynecol Obstet       Date:  2012-10-19       Impact factor: 2.344

Review 6.  Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients.

Authors:  Michael Lux; Thomas Hildebrandt; Elke Beyer-Finkler; Mayada Bani; Christian Loehberg; Sebastian Jud; Claudia Rauh; Michael Schrauder; Peter Fasching; Matthias Beckmann
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

7.  [Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation].

Authors:  M Beckmann; C Sell; M Aydogdu; S Y Brucker; T Fehm; W Janni; R Kreienberg; S Kümmel; M Neumann; A Scharl; B Schleicher; D Wallwiener; A Wöckel; P A Fasching; M P Lux
Journal:  Gesundheitswesen       Date:  2015-08-06

8.  Disease Management Project Breast Cancer in Hesse - 5-Year Survival Data: Successful Model of Intersectoral Communication for Quality Assurance.

Authors:  C Jackisch; A Funk; K König; D Lubbe; B Misselwitz; U Wagner
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03       Impact factor: 2.915

9.  Economic burden of cancer across the European Union: a population-based cost analysis.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair Gray; Richard Sullivan
Journal:  Lancet Oncol       Date:  2013-10-14       Impact factor: 41.316

10.  Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study.

Authors:  M P Lux; C S Sell; P A Fasching; J Seidl-Ertel; M R Bani; M G Schrauder; S M Jud; C R Loehberg; C Rauh; A Hartmann; R Schulz-Wendtland; V Strnad; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-08       Impact factor: 2.915

  10 in total
  1 in total

1.  Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy.

Authors:  Michael G Schrauder; Lisa Brunel-Geuder; Lothar Häberle; Marius Wunderle; Juliane Hoyer; Roland Csorba; André Reis; Rüdiger Schulz-Wendtland; Matthias W Beckmann; Michael P Lux
Journal:  Eur J Med Res       Date:  2019-09-14       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.